Lena Håglin
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Lena Håglin has a total of 11 co-authors. Here are the top co-authors by number of shared publications:
Lennart Bäckman
Department of Public Health and Clinical Medicine, Family Medicine, Umeå University
4 shared publicationsBirgitta Törnkvist
Department of Public Health and Clinical Medicine, Family Medicine, Umeå University, SE-901 87, Umeå, Sweden
2 shared publicationsL. Bäckman
Department of Public Health and Clinical Medicine, Family Medicine, Umeå University, SE-901 87, Umeå, Sweden
2 shared publicationsL. Forsgren
Department of Clinical Sciences, Neurosciences, Umeå University, SE-901 87, Umeå, Sweden
2 shared publicationsMona Edström
Department of Clinical sciences, Neurosciences, Umeå University, SE-901 87 Umeå, Sweden
2 shared publicationsSofia Håglin
Department of Public Health and Clinical Medicine, Family Medicine, Umeå University
2 shared publications
Latest Publications
- Open Access
- 15 January 2026
- Published by Frontiers Media SA in Frontiers in Nutrition
- Vol. 12, 1741580
The inverse relation between changes in body weight and serum phosphate expresses weight loss after lifestyle intervention in non-smokers and smokers, but not in subjects who quit smoking
Background/objectives: Metabolic alterations, physical activity, and dietary pattern together can explain why smoking cessation (SC) often results in weight gain. We studied changes in weight and changes in cardiovascular (CVD) risk factors after an intervention that included an exercise program, dietary advice, and stress management. Subjects/methods: The patient population ( n = 1,782) attended the Vindeln Patient Education Centre (VPE-center) for a 4-week comprehensive lifestyle intervention program, which included the option of smoking cessation. The data were collected before and after, at either the 6- or 12-month follow-up on 247 smokers, 95 former smokers, and 1,440 non-smokers. Results: A high CVD-risk population lost weight and had decreased serum triglyceride (S-TG) and increased serum phosphate (S-P) at the 6- or 12-month follow-up. At baseline, smokers and former smokers had higher S-TG and lower systolic blood pressure (SBP) than non-smokers. Smokers had higher S-P at baseline and higher S-TG at follow-up than non-smokers. A daily energy intake of around 6,300 kJ (1,500 kcal) and a schedule of physical activity resulted in weight loss, but to a significantly lesser extent in patients who quit smoking compared to patients who continued to smoke or stayed as non-smokers. With SC, a decrease in S-P was associated with weight gain, whereas an increase in S-P was associated with weight loss. Conclusion: An interaction between smoking habits, body mass index (BMI), and S-P may express a metabolic change that contributes to the degree of weight loss. Differences in changed metabolic response according to smoking habits express effects from smoking cessation, besides differences in the amount of weight change.
- 15 January 2026
- Published by Frontiers Media SA in Frontiers in Nutrition
- Vol. 12, 1741580
Open AccessThe inverse relation between changes in body weight and serum phosphate expresses weight loss after lifestyle intervention in non-smokers and smokers, but not in subjects who quit smoking
Background/objectives: Metabolic alterations, physical activity, and dietary pattern together can explain why smoking cessation (SC) often results in weight gain. We studied changes in weight and changes in cardiovascular (CVD) risk factors after an intervention that included an exercise program, dietary advice, and stress management. Subjects/methods: The patient population ( n = 1,782) attended the Vindeln Patient Education Centre (VPE-center) for a 4-week comprehensive lifestyle intervention program, which included the option of smoking cessation. The data were collected before and after, at either the 6- or 12-month follow-up on 247 smokers, 95 former smokers, and 1,440 non-smokers. Results: A high CVD-risk population lost weight and had decreased serum triglyceride (S-TG) and increased serum phosphate (S-P) at the 6- or 12-month follow-up. At baseline, smokers and former smokers had higher S-TG and lower systolic blood pressure (SBP) than non-smokers. Smokers had higher S-P at baseline and higher S-TG at follow-up than non-smokers. A daily energy intake of around 6,300 kJ (1,500 kcal) and a schedule of physical activity resulted in weight loss, but to a significantly lesser extent in patients who quit smoking compared to patients who continued to smoke or stayed as non-smokers. With SC, a decrease in S-P was associated with weight gain, whereas an increase in S-P was associated with weight loss. Conclusion: An interaction between smoking habits, body mass index (BMI), and S-P may express a metabolic change that contributes to the degree of weight loss. Differences in changed metabolic response according to smoking habits express effects from smoking cessation, besides differences in the amount of weight change.
- 28 July 2025
- Published by Elsevier in The American Journal of Clinical Nutrition
- Vol. 122 (4) , 1086-1092
Investigating the impact of body weight changes and blood lipids on risk for mild cognitive impairment in Parkinson’s disease: a prospective cohort study
- 28 July 2025
- Published by Elsevier in The American Journal of Clinical Nutrition
- Vol. 122 (4) , 1086-1092
Investigating the impact of body weight changes and blood lipids on risk for mild cognitive impairment in Parkinson’s disease: a prospective cohort study
- Open Access
- 2 July 2022
- Published by Wiley in Parkinson's Disease
- Vol. 2022, 1-8
Handgrip Strength and Anthropometry in Parkinson’s Disease at Diagnosis
Objectives. To investigate how age, malnutrition, and the level of plasma cortisol and phosphate in patients with Parkinson’s disease (PD) at time of diagnosis are associated with body composition and handgrip strength in males and females compared to controls. Materials & Methods. This cross-sectional study includes baseline data from a cohort of newly diagnosed patients with Parkinson’s disease (N = 75; M/F = 41/34) in the New Parkinsonism in Umeå study (NYPUM). Body Impedance (BIS), handgrip strength (HGS) assessments, and evaluation of risk for malnutrition (Mini Nutritional Assessment (MNA) score) and cognitive performance (Mini-Mental State Examination (MMSE)) were performed at time of PD diagnosis. Results. Low fat-free mass index (FFMI), MNA score, and a high Unified Parkinson’s Disease Rating Scale (UPDRS-total and UPDRS-III) were associated with high daytime levels of P-cortisol in total PD population but not in controls. Partial correlations reveal that high fat mass percent (FM (%)) and low FFMI were associated with older age in males with PD but not females with PD. Risk of malnutrition was associated with P-cortisol in males but not in females with PD (r = −0.511, , and n = 41 and r = −0.055, , and n = 34, respectively). Multiple linear regressions show that an interaction between P-cortisol and P-phosphate, older age, and high UPDRS-III score were associated with HGS in total patient population and males but not females. Conclusions. Age- and disease-associated risk factors that decrease muscle mass and HGS and increase FM (%) in patients with PD differ between males and females by an association with levels of cortisol and phosphate.
- 2 July 2022
- Published by Wiley in Parkinson's Disease
- Vol. 2022, 1-8
Open AccessHandgrip Strength and Anthropometry in Parkinson’s Disease at Diagnosis
Objectives. To investigate how age, malnutrition, and the level of plasma cortisol and phosphate in patients with Parkinson’s disease (PD) at time of diagnosis are associated with body composition and handgrip strength in males and females compared to controls. Materials & Methods. This cross-sectional study includes baseline data from a cohort of newly diagnosed patients with Parkinson’s disease (N = 75; M/F = 41/34) in the New Parkinsonism in Umeå study (NYPUM). Body Impedance (BIS), handgrip strength (HGS) assessments, and evaluation of risk for malnutrition (Mini Nutritional Assessment (MNA) score) and cognitive performance (Mini-Mental State Examination (MMSE)) were performed at time of PD diagnosis. Results. Low fat-free mass index (FFMI), MNA score, and a high Unified Parkinson’s Disease Rating Scale (UPDRS-total and UPDRS-III) were associated with high daytime levels of P-cortisol in total PD population but not in controls. Partial correlations reveal that high fat mass percent (FM (%)) and low FFMI were associated with older age in males with PD but not females with PD. Risk of malnutrition was associated with P-cortisol in males but not in females with PD (r = −0.511, , and n = 41 and r = −0.055, , and n = 34, respectively). Multiple linear regressions show that an interaction between P-cortisol and P-phosphate, older age, and high UPDRS-III score were associated with HGS in total patient population and males but not females. Conclusions. Age- and disease-associated risk factors that decrease muscle mass and HGS and increase FM (%) in patients with PD differ between males and females by an association with levels of cortisol and phosphate.
- 1 June 2020
- Published by Elsevier in Clinical Nutrition ESPEN
- Vol. 37, 93-99
Low plasma thiamine and phosphate in male patients with Parkinson's disease is associated with mild cognitive impairment
- 1 June 2020
- Published by Elsevier in Clinical Nutrition ESPEN
- Vol. 37, 93-99
Low plasma thiamine and phosphate in male patients with Parkinson's disease is associated with mild cognitive impairment
- Open Access
- 1 February 2020
- Published by Elsevier in Clinical Nutrition Experimental
- Vol. 29, 18-29
Low level of phosphate in male patients reporting swallowing disturbances in early Parkinson's disease
- 1 February 2020
- Published by Elsevier in Clinical Nutrition Experimental
- Vol. 29, 18-29
Open AccessLow level of phosphate in male patients reporting swallowing disturbances in early Parkinson's disease
- Open Access
- 16 January 2020
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 15 (1) , e0227692
Obesity, smoking habits, and serum phosphate levels predicts mortality after life-style intervention
Life-style interventions, including smoking cessation and weight control are of importance for managing future escalating prevalence of obesity. Smoking habits and obesity have jointly great impact on mortality, however mechanisms behind the effect and variables involved in the obesity paradox is still unknown. This study examines risk factors for all-cause, cardiovascular, and cancer mortality in males and females with high cardiovascular risk, mediated by smoking habits, body mass index (BMI, kg/m2), and serum phosphate (S-P) levels. Patients were admitted to the Vindeln Patient Education Center in groups of 30 for a four-week residential comprehensive program (114 hours) focusing on smoking cessation, stress reduction, food preferences and selections, and physical exercise. The follow-up, in years from 1984 to 2014 corresponds to 30 years. This study included 2,504 patients (1,408 females and 1,096 males). Cox regression analysis was used to assess mortality risk associated with smoking habits, low and high BMI, and low and high S-P levels. High BMI (>34,2 kg/m2), current smoking, type 2 diabetes mellitus (T2DM), high serum calcium (S-Ca), mmol/L and high systolic blood pressure (SBP, mmHg) were associated with all-cause mortality irrespective of sex. Former and current smoking females had a high all-cause mortality (adjusted hazard ratio [HR] 1.581; 95% CI 1.108–2.256, adjusted hazard ratio [HR] 1.935; 95% CI 1.461–2.562, respectively) while current smoking and high BMI increased risk for cardiovascular mortality (adjusted hazard ratio [HR] 3.505; 95% CI 2.140–5.740 and [HR] 1.536; 95% CI 1.058–2.231, respectively). Neither low nor high levels of S-P predicted all-cause, cardiovascular disease (CVD) and cancer mortality in males or females while low levels of S-P predicted all-cause mortality in smokers (adjusted hazard ratio [HR] 1.713; 95% CI 1.211–2.424). In non-smokers, low BMI (2) was protecting and high BMI a risk for all-cause mortality. In males, ischemic heart disease (IHD), and low serum albumin (S-Alb) were associated with all-cause mortality. In females, an interaction between high BMI and smoking (HbmiSM) decreased the cardiovascular mortality (adjusted hazard ratio [HR] 0.410; 95% CI 0.179–0.937, respectively). High BMI and current smoking were associated with all-cause mortality in both males and females in the present high cardiovascular-risk cohort. In current smokers and non-smokers, T2DM and high S-Ca were associated with an increase in all-cause mortality, while low S-P was associated with all-cause mortality in smokers. Interaction between high BMI and smoking contribute to the obesity paradox by being protective for cardiovascular mortality in females.
- 16 January 2020
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 15 (1) , e0227692
Open AccessObesity, smoking habits, and serum phosphate levels predicts mortality after life-style intervention
Life-style interventions, including smoking cessation and weight control are of importance for managing future escalating prevalence of obesity. Smoking habits and obesity have jointly great impact on mortality, however mechanisms behind the effect and variables involved in the obesity paradox is still unknown. This study examines risk factors for all-cause, cardiovascular, and cancer mortality in males and females with high cardiovascular risk, mediated by smoking habits, body mass index (BMI, kg/m2), and serum phosphate (S-P) levels. Patients were admitted to the Vindeln Patient Education Center in groups of 30 for a four-week residential comprehensive program (114 hours) focusing on smoking cessation, stress reduction, food preferences and selections, and physical exercise. The follow-up, in years from 1984 to 2014 corresponds to 30 years. This study included 2,504 patients (1,408 females and 1,096 males). Cox regression analysis was used to assess mortality risk associated with smoking habits, low and high BMI, and low and high S-P levels. High BMI (>34,2 kg/m2), current smoking, type 2 diabetes mellitus (T2DM), high serum calcium (S-Ca), mmol/L and high systolic blood pressure (SBP, mmHg) were associated with all-cause mortality irrespective of sex. Former and current smoking females had a high all-cause mortality (adjusted hazard ratio [HR] 1.581; 95% CI 1.108–2.256, adjusted hazard ratio [HR] 1.935; 95% CI 1.461–2.562, respectively) while current smoking and high BMI increased risk for cardiovascular mortality (adjusted hazard ratio [HR] 3.505; 95% CI 2.140–5.740 and [HR] 1.536; 95% CI 1.058–2.231, respectively). Neither low nor high levels of S-P predicted all-cause, cardiovascular disease (CVD) and cancer mortality in males or females while low levels of S-P predicted all-cause mortality in smokers (adjusted hazard ratio [HR] 1.713; 95% CI 1.211–2.424). In non-smokers, low BMI (2) was protecting and high BMI a risk for all-cause mortality. In males, ischemic heart disease (IHD), and low serum albumin (S-Alb) were associated with all-cause mortality. In females, an interaction between high BMI and smoking (HbmiSM) decreased the cardiovascular mortality (adjusted hazard ratio [HR] 0.410; 95% CI 0.179–0.937, respectively). High BMI and current smoking were associated with all-cause mortality in both males and females in the present high cardiovascular-risk cohort. In current smokers and non-smokers, T2DM and high S-Ca were associated with an increase in all-cause mortality, while low S-P was associated with all-cause mortality in smokers. Interaction between high BMI and smoking contribute to the obesity paradox by being protective for cardiovascular mortality in females.
- 1 July 2010
- Published by Elsevier in Archives of Gerontology and Geriatrics
- Vol. 51 (1) , 26-30
Predisposing chronic diseases and hypophosphatemia in patients with influenza
- 1 July 2010
- Published by Elsevier in Archives of Gerontology and Geriatrics
- Vol. 51 (1) , 26-30
Predisposing chronic diseases and hypophosphatemia in patients with influenza